AR and prostate carcinoma: Whereas, PSA codes for a serine protease downstream to the AR. Targeting AR is reported to induce apoptosis, autophagic cell death and programmed necrosis (25, 26) and it is currently used as a constructive approach to inhibit prostate cancer cell proliferation.